Smoking

The use of tobacco products is a potential risk factor for worse COVID-19 outcomes, and a new paper in the Annals of the American Thoracic Society highlights types of research to better understand this relationship.

Exposure to passive smoking from childhood through adulthood was associated with increased risk for non-alcoholic fatty liver disease, according to study results.

Low FEV1/slow vital capacity in current and former smokers with normal spirometry may aid in the identification of individuals who are at increased risk for COPD, researchers reported in Chest.

The longer an individual smoked, the greater his or her odds were for COVID-19 hospitalization and death, an analysis of data from a single health system showed.

Current smoking appears to increase individual risk for developing symptomatic COVID-19, according to results published in Thorax.

Research published in Stroke indicated a causal association between smoking and risk for nontraumatic subarachnoid hemorrhage among individuals of European descent in Britain.

Patients with inflammatory bowel disease who either currently or formerly smoked cigarettes were at higher risk for colorectal neoplasia, according to study results.

Lower oral microbiome diversity and an abundance of specific taxa in the respiratory tract may be associated with greater risk for lung cancer in never smokers, researchers reported in Thorax.

A recent study showed that cigarette smoking was associated with an increased risk for colorectal cancer. It was the top story in gastroenterology last week.

Low-dose chest CT screening resulted in “notable detection” of lung nodules among never smokers, researchers reported in the European Respiratory Journal.